Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Maine Children's Medical Center
mi
from
Portland, ME
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Maine Children's Medical Center
mi
from
Portland, ME
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Tufts Clinical Pharmacology Study Unit
mi
from
Boston, MA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Tufts Clinical Pharmacology Study Unit
mi
from
Boston, MA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Mayo Clinic Rochester
mi
from
Rochester, MN
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Washington University
mi
from
St. Louis, MO
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
University of Nebrasaka Medical Center
mi
from
Omaha, NE
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
University of Nebrasaka Medical Center
mi
from
Omaha, NE
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Newark Beth Israel Medical Center
mi
from
Newark, NJ
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Newark Beth Israel Medical Center
mi
from
Newark, NJ
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Mary M Parkes Center for Asthma, Allergy and Pulmonary Care - University of Rochester
mi
from
Rochester, NY
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Mary M Parkes Center for Asthma, Allergy and Pulmonary Care - University of Rochester
mi
from
Rochester, NY
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Case Western Reserve Univ
mi
from
Cleveland, OH
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
mi
from
Cleveland, OH
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Ohio State University
mi
from
Columbus, OH
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Legacy Clinic Northwest
mi
from
Portland, OR
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Legacy Clinic Northwest
mi
from
Portland, OR
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Oregon Health and Science University
mi
from
Portland, OR
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Oregon Health and Science University
mi
from
Portland, OR
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Allegheny Endocrinology Associates
mi
from
Pittsburgh, PA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Allegheny Endocrinology Associates
mi
from
Pittsburgh, PA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Baylor School of Medicine
mi
from
Houston, TX
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Baylor School of Medicine
mi
from
Houston, TX
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Aurora Sinai Medical Center / St. Lukes Medical Center
mi
from
Milwaukee, WI
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Aurora Sinai Medical Center / St. Lukes Medical Center
mi
from
Milwaukee, WI
Laparoscopic Adjustable Gastric Banding With Truncal Vagotomy
Pilot Study Assessing Advantage of Adding Truncal Vagotomy to LAGB
Status: Archived
Wesley Long Community Hopital
mi
from
Greensboro, NC
Laparoscopic Adjustable Gastric Banding With Truncal Vagotomy
Pilot Study Assessing Advantage of Adding Truncal Vagotomy to LAGB
Status: Archived
Updated: 1/1/1970
Wesley Long Community Hopital
mi
from
Greensboro, NC
Effect of Exercise and Diet on Inflammation in Hypertensive Individuals
Sympathetic Nervous System Regulation of Cell Adhesion
Status: Archived
San Francisco General Hospital
mi
from
San Francisco, CA
Effect of Exercise and Diet on Inflammation in Hypertensive Individuals
Sympathetic Nervous System Regulation of Cell Adhesion
Status: Archived
Updated: 1/1/1970
San Francisco General Hospital
mi
from
San Francisco, CA
Effect of Low Socionomic Status and Psychosocial Factors on Cardiovascular Disease Risk in Mexican-American Women
Cardiovascular Risk Disparities: Socio-Emotional Pathways
Status: Archived
San Diego State University, Center for Behavioral and Community Health Research (BACH)
mi
from
San Diego, CA
Effect of Low Socionomic Status and Psychosocial Factors on Cardiovascular Disease Risk in Mexican-American Women
Cardiovascular Risk Disparities: Socio-Emotional Pathways
Status: Archived
Updated: 1/1/1970
San Diego State University, Center for Behavioral and Community Health Research (BACH)
mi
from
San Diego, CA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
University of Alabama - Burmingham
mi
from
Birmingham, AL
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Updated: 1/1/1970
University of Alabama - Burmingham
mi
from
Birmingham, AL
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
University of Southern California Women's and Children's Hospital
mi
from
Los Angeles, CA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Updated: 1/1/1970
University of Southern California Women's and Children's Hospital
mi
from
Los Angeles, CA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
West Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Updated: 1/1/1970
West Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Kansas University Medical Center
mi
from
Kansas City, KA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Updated: 1/1/1970
Kansas University Medical Center
mi
from
Kansas City, KA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Updated: 1/1/1970
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
University of Pittsburg Medical Center
mi
from
Pittsburgh, PA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Updated: 1/1/1970
University of Pittsburg Medical Center
mi
from
Pittsburgh, PA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Allegheny Endocrinology Associates
mi
from
Pittsburgh, PA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Updated: 1/1/1970
Allegheny Endocrinology Associates
mi
from
Pittsburgh, PA
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Vanderbilt University Medical Center
mi
from
Nashville, TN
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Nashville, TN
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Updated: 1/1/1970
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Center for Fertility and Women's Health
mi
from
New Britain, CT
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Updated: 1/1/1970
Center for Fertility and Women's Health
mi
from
New Britain, CT
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Clinical Research Facility
mi
from
Lexington, KY
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Lexington, KY
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Clinical Research Facility
mi
from
Asheville, NC
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Asheville, NC
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Clinical Research Facility
mi
from
Columbus, OH
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Columbus, OH
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Clinical Research Facility
mi
from
Seattle, WA
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Seattle, WA
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Clinical Research Facility
mi
from
Marshfield, WI
Study of Losartan in Pediatric Patients With Hypertension (0954-337)
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Marshfield, WI
Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Archived
Alcon Call Center
mi
from
Fort Worth, TX
Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Home Blood Pressure Telemonitoring and Case Management to Control Hypertension
Home Blood Pressure Telemonitoring and Case Management to Control Hypertension
Status: Archived
HealthPartners Research Foundation
mi
from
Minneapolis, MN
Home Blood Pressure Telemonitoring and Case Management to Control Hypertension
Home Blood Pressure Telemonitoring and Case Management to Control Hypertension
Status: Archived
Updated: 1/1/1970
HealthPartners Research Foundation
mi
from
Minneapolis, MN
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
An 8 Week, Single Masked, Parallel-Group, Exploratory Study Comparing Ocular Surface Signs and Symptoms in Monotherapy Ocular Hypertension or Glaucoma Patients Randomized to Either Xalatan® or Travatan Z®
Status: Archived
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
An 8 Week, Single Masked, Parallel-Group, Exploratory Study Comparing Ocular Surface Signs and Symptoms in Monotherapy Ocular Hypertension or Glaucoma Patients Randomized to Either Xalatan® or Travatan Z®
Status: Archived
Updated: 1/1/1970
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)
Status: Archived
Norman Garrison
mi
from
Montgomery, AL
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)
Status: Archived
Updated: 1/1/1970
Norman Garrison
mi
from
Montgomery, AL
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)
Status: Archived
Centinela Hospital
mi
from
Inglewood, CA
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)
Status: Archived
Updated: 1/1/1970
Centinela Hospital
mi
from
Inglewood, CA
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)
Status: Archived
Louisiana State University Health Sciences Center
mi
from
Shreveport, LA
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)
Status: Archived
Updated: 1/1/1970
Louisiana State University Health Sciences Center
mi
from
Shreveport, LA
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)
Status: Archived
Louisiana State University
mi
from
New Orleans, LA
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)
Status: Archived
Updated: 1/1/1970
Louisiana State University
mi
from
New Orleans, LA
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)
Status: Archived
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)
Status: Archived
Updated: 1/1/1970
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI